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DNA Recognition by the RUNX1 Transcription Factor
Is Mediated by an Allosteric Transition in the
RUNT Domain and by DNA Bending
transcriptional modulators [3, 5, 10]. Nevertheless, they
mediate distinct biological functions and exhibit a
unique spatiotemporal expression pattern during devel-
opment [11–15]. Their unique expression pattern is or-
chestrated through alternative splicing and transcrip-
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and Runx2 play fundamental roles in hematopoietic andWeizmann Institute of Science
Rehovot 76100 osteogenic lineage-specific gene expression and, when
mutated, are associated with human diseases [18–21].Israel
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root ganglia [22].Tel-Aviv University
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globulin fold (Ig fold) similar to that observed in DNA4 Department of Molecular Genetics
Weizmann Institute of Science binding domains of other proteins [23, 24]. The NMR
structures of CBF have shown a fold related to the Rehovot 76100
Israel barrel oligomer binding domain [25–27]. Crystal struc-
tures of RD complexed to either CBF or to DNA or to
both components followed, providing a detailed map-
ping of the RD/CBF dimerization region and of theSummary
RD/DNA interface [28–30]. The crystallographic studies
coupled with DNA binding and transcriptional assaysThe Runt domain proteins are transcription regulators
provided insight into the structural basis of the detrimen-of major developmental pathways. Here we present
tal effects of specific point mutations in the two proteinsthe crystal structures of the Runt domain (RD) of the
that are associated with the development of human dis-human protein RUNX1 and its DNA binding site in their
eases [29–31]. However, our understanding of the struc-free states and compare them with the published crys-
tural basis of specificity of interaction in this system istal structures of RD bound to DNA and to the partner
not complete without visualizing the structures of theprotein CBF. We demonstrate that (1) RD undergoes
various components in their free states and comparingan allosteric transition upon DNA binding, which is
them to the corresponding molecules in the complexedfurther stabilized by CBF, and that (2) the free DNA
state.target adopts a bent-helical conformation compatible
Here we present the crystal structure of the Runt do-with that of the complex. These findings elucidate the
main of the human protein RUNX1 determined at 2.5 A˚mechanism by which CBF enhances RD binding to
resolution and that of a DNA dodecamer, AGCTGCGGTDNA as well as the role of the intrinsic conformation
CAT, incorporating the consensus seven-base pair bind-of the DNA target in the recognition process.
ing site (underlined) at 2.8 A˚ resolution. The comparative
analysis of the free RD and the previously reported com-
Introduction plexes of RD with DNA and CBF [29, 30] demonstrates
that the protein undergoes an allosteric transition upon
The RUNX transcription factors (previously known as binding to DNA, which is further supported by CBF.
AML, CBF, or PEBP2) are key regulators in a diverse The transition from the free conformational state to the
range of developmental pathways. They comprise a bound state is accommodated by cooperative changes
small family, whose members contain a highly con- in several loops of RD that mediate protein-DNA and
served region of 128 amino acids, designated the “Runt protein-protein interactions. In contrast, the conforma-
domain” (RD), found in the Drosophila protein Runt. The tion of the free DNA binding site is similar to that of the
RD spans the N-terminal part of the molecule and medi- protein-bound DNA targets. These findings provide new
ates binding to a target DNA sequence PyGPyGGTPy insights into the mechanism of DNA recognition by this
(Py, pyrimidine) as well as protein-protein interaction unique family of transcription regulators.
with an unrelated partner protein, CBF, which alone
does not bind DNA but increases the DNA binding affin- Results and Discussion
ity of RUNX (reviewed in [1–3]).
Three mammalian genes RUNX1, RUNX2, and RUNX3 An Overall View of the Runt Domain
were identified [4, 5], and their genomic structure was The two independent RD molecules in the crystal struc-
elucidated [6–9]. The RUNX proteins have the ability to ture, shown superimposed in Figure 1A, are highly simi-
bind to the same DNA motif and to act as either activa- lar, with an RMS deviation of 0.6 A˚ with the backbone
tors or repressors through interactions with common
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Figure 1. Structures of the Free and Complexed Runt Domains
(A) The two independent RD molecules of the present study superimposed on each other (shown in magenta and gold). The numbering
scheme of the loops and  strands is as in [29]. All figures were produced with the MOLSCRIPT [58] and Raster3D [59] programs.
(B) Amino acid sequence and the secondary structure of the free RD.
(C) Comparison of the Runt domains from four crystal structures using C atoms: the free RD molecules from the present study (magenta
and gold), from the RD/CBF complex (blue; ID code 1E50), from the RD/DNA complex (green; ID code 1HJC), and from the RD/CBF/DNA
complex (cyan; ID code 1H9D).
atoms and 1.4 A˚ with all atoms. This similarity and the 30]. Five loops, L11, L2, L3, L8, and L6, run along the
long axis of the molecule and are nearly equally spacedhigh solvent content of more than 70% (see Experimen-
tal Procedures) indicate that there is minimal influence apart. The molecule is capped by four loops (L1, L4, L7,
and L10) that are interconnected by electrostatic andof crystal packing interactions and that the crystal struc-
ture closely represents the dominant free RD conforma- hydrophobic interactions (see below).
A comparison between the structure of the free RDtion in solution. The structure of the RD molecule is
made up of 12  strands separated by flexible loops and the structures of RD complexed to CBF, DNA,
or both reveals significant conformational alterationsforming an S-type immunoglobulin fold similar to that
shown by the crystal structures of RD bound to DNA between the free molecule and each of the bound mole-
cules. The superposition of five RD molecules (residuesand to CBF [28–30]. Eight antiparallel  strands at the
upper part of the molecule form a  sandwich that pro- 60–174) from this study and the previously reported
crystal structures [28–30] is shown in Figure 1C. The N-vides a structural scaffold for several key loops that
interact with DNA or with CBF. In addition, two short and C-terminal regions were omitted from this compari-
son, as these were disordered in several of the crystalantiparallel  strands (6 and 9) and two parallel 
strands (3 and 12) located at the lower part of the structures. Several loops undergo major changes upon
RD binding to DNA and to CBF. The most prominentmolecule support four loops at the bottom of the mole-
cule (L3, L5, L9, and L12), each playing a critical role in change is in the conformation of a “meridian” loop, L11.
In the free molecule, this loop is longer, by one residue,stabilizing the protein-DNA interface, as shown by the
crystal structures of the corresponding complexes [29, and the adjacent 11 strand is shorter, by one residue,
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compared with the bound molecule (Figure 1B). In the an intermediate timescale. Also, the free protein was
unstable at high concentrations, room temperature, andfree RD molecule, this loop points toward the N terminus
and is equally spaced between the polypeptide chains low salt content [32]. DNA binding to this protein resulted
in the appearance of many additional resonances andof 2-L2 and L9-10, whereas the same loop region in
the complex with either CBF or DNA is pointing in the major changes in the chemical shifts. However, even
in the DNA-protein complex, no assignments could beopposite direction, making close contacts with residues
within the L9-10 region. Other significant changes be- made to the backbone amides of residues 163–166 com-
prising L11 or of the adjacent 169–173 region formingtween the free and bound structures are displayed by
three other loop domains: L4, L5, and L9. Loops L4 and the part of L12 that is involved in sequence-specific
interactions with the DNA major groove. The other pub-L9 are considered particularly flexible because of the
presence of several glycine residues, as demonstrated lished NMR studies were performed on complexes of
RD with DNA and with both DNA and CBF [23, 24, 33].by significant alterations in these regions among the
various RD structures (Figure 1C). The NMR data on RD from the human RUNX1 protein
(amino acids 51–188) by Nagata et al. [24] showed clus-To understand the effects caused by the interactions
of the Runt domain with DNA or with CBF, we must tering of NH chemical shift changes upon CBF binding
to the RD/DNA complex, for residues 158–163, whichperform a detailed comparative analysis of all the protein
regions that are involved in such interactions. The avail- constitute 11 and the first two residues of L11. The
NMR spectra of Tang et al. [33] on RD from Runx1 (aminoability of several independent crystal structures of RD
in its free state and in the various complexed states acids 41–214) showed substantial NH and C chemical
shift perturbations in the L11 region (residues 159–166)allows for a meaningful comparative analysis of such
effects and minimizes a possible bias caused by lack upon CBF binding. Difficulties in the assignment of
residues in L11 and the neighboring region of the RD/of resolution or crystal-packing interactions.
DNA complex were encountered because of exchange
broadening, but this obscurity was markedly reduced
An Allosteric Transition in the Runt Domain in the ternary complex with CBF [33]. The authors sug-
Is Induced upon Binding to DNA and to CBF gested that RD exchanges between two or more confor-
The major conformational changes in the Runt domain mations in the L11 region and one conformation pre-
upon binding to DNA or CBF are displayed by three dominates upon binding to CBF [33]. It is therefore
loops: L11, L9, and L5. Whereas L11 undergoes a likely that the two conformational states of L11 observed
dramatic conformational switch accommodated by in the various crystal structures are in equilibrium with
changes in the backbone of several consecutive resi- each other in solution and that the unbound conforma-
dues (162–166), the two other loops undergo essentially tion (L11-I) is energetically favorable in the free state of
en-block movements toward L11, except for L9 of the the molecule, whereas the bound conformation (L11-II)
RD/CBF complex. The conformation of L9 in the RD/ is more stable in the presence of DNA and becomes
CBF crystal structure [28] deviates from that of the further stabilized by CBF, as discussed below.
other structures (Figure 2A), demonstrating the signifi- Of the three loops that show major alterations upon
cant plasticity of this loop. DNA binding, only L9 interacts directly with the DNA
Two unique conformational states of L11 are dis- target [29, 30]. However, the change observed in L9 is
played by the various structures shown in Figure 2A: intimately linked to those of the two other loops, L11
one is associated with the free RD and is referred to and L5, as described below. The requirement for a major
as L11 type-I conformation, or L11-I, and the other is shift in the position of the L9 loop is elucidated by com-
associated with each of the RD complexes (RD/DNA, paring the relative arrangements of the structural ele-
RD/CBF, and RD/CBF/DNA) and is referred to as L11- ments of RD that participate in direct and indirect inter-
II. A close-up view of the hydrophobic pocket associated actions with the DNA target shown in Figure 3A.
with L11 is shown in Figure 2B. The side chains of His163 The amino acids that interact sequence specifically
and Ala165 change environments between the two con- with the DNA binding site are located on L3, L12, L9,
formations. In the free molecule, His163 is part of the and 3. These include Arg80, Lys83, Arg142, Val170,
hydrophobic pocket but Ala165 is directed toward the Asp171, Arg174, and Arg177 (the later is not shown here,
solvent, whereas, in each of the bound molecules, as the extreme C-terminal region is disordered in the
His163 points toward the solvent and Ala165 is at the free RD structure). In addition, four amino acids located
hydrophobic pocket. In addition, Tyr162 of the free mol- on 9, L9, and 12, including Arg135, Arg139, Gly143,
ecule forms a hydrogen bond with the backbone of the and Lys167 (Arg135 is not shown in Figure 3A for clarity),
L2 loop. The same arrangement is observed in the other make direct contacts with the DNA backbone [29, 30].
molecule of the crystal structure of the free RD (data The conformations and relative orientations of the three
not shown). loops that form the sequence-specific interface are sup-
NMR data on the free RD molecule was reported by ported by the two short parallel  strands (3 and 12) as
Perez-Alvarado et al. [32], who used a construct of the well as by intra- and interloop interactions, shown in
mouse Runx2 protein (previously known as AML3/ Figure 3A. Longer-range support is provided by the two
CBFA1/PEBP2A, the residue numbering of 90–225 antiparallel strands, 6 and 9 (shown in Figure 4). When
used in their report corresponds to 47–182 of the RUNX1 anchored on the DNA helix, the three “sequence-spe-
numbering). Twenty-five percent of the amide reso- cific” loops are maintained by “in-line” van der Waals
nances were not observed for the free RD because of interactions from Pro173 via His78 and Lys167 to the
backbone of L9 as well as by a nearly linear array ofbroadening arising from conformational exchange on
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Figure 2. Comparison of the Loop Conformations in the Four RD Structures with the Same Color Scheme as in Figure 1
(A) A view of the three loops, L5, L9, and L11, and adjacent regions showing amino acids that interact with CBF and DNA. The corresponding
side chain atoms that interact with CBF or DNA are highlighted for the ternary complex RD (cyan); atoms that interact with CBF are shown
as red spheres (oxygen atoms), and those that interact with DNA are shown as blue spheres (nitrogen atoms).
(B) Changes in the hydrophobic environment of the L11 loop as a consequence of binding to DNA or CBF.
salt bridge and attractive interactions of the type thereby stabilizing the type-II conformation of L11 illus-
trated in Figure 3B. In other words, the coupling betweenCH3…O and CH3…NH2 formed by Arg174, Asp171,
Val170, and Arg139 (shown in Figure 3A). Except for the the en-bloc motion of L9 and the conformational transi-
tion of L11 from the extended type-I conformation toextreme C terminus, the shape and spatial arrangement
of L3, L12, and the adjacent  strands are very similar the more constricted type-II conformation is achieved by
formation of a long hydrogen bond ladder, or “zipper,”between the free RD and the RD bound to DNA (Figure
3A) or bound to both DNA and CBF (Figure 4). Thus, extending from the two antiparallel strands 10 and 11
all the way to the L9 loop (Figure 3B). This array isthe corresponding amino acids of the free RD can readily
form sequence-specific interactions with the DNA bases identical to that displayed by RD bound to either CBF
or to both DNA and CBF (data not shown).at the major groove as well as hydrogen bonds with the
DNA backbone (shown in Figure 4). This is not the case,
however, for two residues of L9. As illustrated by Figures How Does CBF Enhance DNA Binding
by the Runt Domain3A and 4, a major positional rearrangement of L9 toward
L11-12 is required to allow the interaction of Arg142 On the basis of the comparison between the RD/DNA
and the RD/CBF/DNA crystal structures and the re-with the two bases at the DNA minor groove and that
of the backbone amide of Gly143 with the phosphate ported NMR data, Tahirov et al. proposed that CBF
binding to RD plays a decisive role in the allosteric regu-group of the DNA backbone, shown by the crystal struc-
tures of the protein-DNA complexes [29, 30]. This lation of the RD/DNA interaction [29]. The present study
further supports this notion by revealing the allostericchange is achieved by small adjustments in the back-
bone torsion angles at the junctions between L9 and transition in the Runt domain upon DNA binding, which
is further supported by CBF, as outlined in the follow-the adjoining  strands, whereas the conformation of
L9 is essentially unaltered. Ser140 plays a key structural ing. It is interesting to note that CBF is not involved in
any direct contacts with the RD structural elements thatrole in buttressing the flexible L9 loop via intra- and
interloop hydrogen bonds observed in both the free and interact directly with the DNA. This is unlike other hetero-
dimeric transcription regulators, where the partner pro-the DNA-bound states (Figures 3A, 3B, and 5A), and
mutations in this residue result in dysfunction [34–37]. tein either binds directly to DNA or stabilizes the specific
DNA binding motif (reviewed in [38]). The major impactThe realignment of L9 induced by DNA binding, is
associated with a corresponding shift in L5 and the of CBF interaction with RD is in supporting the struc-
ture of the three interlinked loops, L11-L9-L5, in theirmajor conformational transition in L11. The L9 move-
ment toward L11-12 facilitates the formation of several DNA binding mode, characterized by the type-II confor-
mation of L11 and the significant shifts of L9 and L5parallel hydrogen bonds between L9-10 and L11,
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toward L11 relative to those of the free molecule (Fig- required for DNA binding but would interfere with resi-
dues of CBF (shown in Figure 3C) at the RD/CBFure 2A).
The stabilization of L11-II conformation in the pres- interface.
The corresponding three amino acids (161, 66, andence of CBF can be rationalized on the basis of a
network of hydrogen bonds and hydrophobic interac- 163) in mammalian RD proteins and of other species
are shown in Table 1. Thr161 is conserved among thetions observed between the two molecules. Three amino
acids of the Runt domain, Thr161 (11), Asp66 (L1), various organisms, except in the Drosophila Runt, where
it is substituted by Serine (see below). Homologous sub-and His163 (L11), form two short and optimally oriented
hydrogen bond contacts in the presence of CBF. The stitutions at positions 66 and 163 shown by the sea
urchin SpRunt (Asp66Glu and His163Asn) and the zebra-spatial arrangement of this triad is buttressed by inter-
molecular hydrogen bonds between Asn104 (CBF) and fish Runx1 (His163Gln) are in accord with the proposed
mechanism. Nonhomologous changes at the two posi-Thr161 (RD) and between Lys11 (CBF) and Asp66 (RD),
as well as the interaction of His163 (RD) with the hy- tions are displayed by the Drosophila Runt (Asp66Gly)
and Lozenge (Asp66Ser and His163Ala) and by the C.drophobic region made by Phe17 and Phe18 of CBF
[29, 30] illustrated in Figure 3C. The same interaction elegans Run (Asp66Ser and His163Lys). The C. elegans
RD protein is unique in this series, with a charged aminonetwork is also observed in the RD/CBF complex [28].
In the absence of CBF, the three amino acids (His163, acid at position 163. L11-II conformation with Lys163
exposed at the solvent would be favored over the alter-Thr161 and Asp66) are not involved in close direct inter-
actions among themselves (Figures 3B and 3C). In the native L11-I arrangement, with Lys163 being close to the
hydrophobic pocket formed by neighboring residues.free molecule, His163 is pointing toward the opposite
direction, stabilizing the L11-I conformation as dis- Also, Phe162Val and Ala165Val substitutions present in
the Run protein would further augment the hydrophobiccussed above. In the RD/DNA complex displaying the
L11-II conformation, the hydrogen-bonded triad is not interactions associated with the L11-II configuration
shown in Figure 2B. It is therefore likely that, in the C.utilized, as both Asp66 and Thr161 are not properly
supported to form the interactions shown by the com- elegans RD, the DNA-compatible form characterized by
the type-II conformation of L11 is highly populated inplex with CBF (Figure 3C). Instead, stabilization of L11-
II in the crystal structure of the RD/DNA complex is solution, and, hence, a CBF-like protein may not be
required to support the protein’s interaction with DNA.partly achieved by hydrophobic interactions between
Thr161 and Thr147 from opposite strands (10 and 11) The Drosophila Runt and Lozenge display two different
configurations of the triad: Ser161-Gly66-Ser163 andand electrostatic interactions formed by bifurcated hy-
drogen bonds between Asp66 and His163 (Figure 3B). Thr161-Ser66-Ala163 (Table 1). In Runt, the hydroxyl
side chains of Ser161 and Ser163 could form a hydrogenThe role of the amino acid triad in stabilizing the L11-
II conformation in the presence of CBF is further clari- bond between them, with Ser161 acting also as a hydro-
gen-bond acceptor from Asn104 of CBF, thereby sup-fied by the available DNA binding data on mutated RD
proteins and by the natural substitutions of the three porting the L11-II conformation. In Lozenge, a direct
hydrogen bond between Thr161 and Ser66 as well asamino acids in RD proteins of other species. The effect
of Asp66Ala mutation in RD on DNA binding and dimer- the corresponding one with Asn104 of CBFwould sup-
port the L11-II conformation. However, His163Ala re-ization with CBFwas studied by electrophoretic mobil-
ity shift assay (EMSA) [29, 31], surface plasmon reso- placement in this protein would place the side chain of
Ala163 more than 5 A˚ away from either Ser66 or Thr161.nance (SPR) [29], and isothermal titration calorimetry
(ITC) [29]. This mutation was shown to slightly enhance It is likely, however, that Ala163 would contribute to the
DNA-compatible conformation of L11 by buttressing thethe stability of the RD/CBF complex, probably because
of relief of steric hindrance with CBF and, hence, en- hydrogen bond interaction of Thr147 with the backbone
amide of L11 (shown in Figure 3B) through hydrophobictropic gain in this interaction [29]. It does, however, show
reduced binding to DNA in comparison with wt RD, most interactions between the methyl groups of the two amino
acids. The nonhomologous amino acid changes in thelikely because of destabilization of L11-II conformation
in the absence of support by Asp66. The reduction in Drosophila RD proteins may be related to the presence
of two CBF homologs (Brother and Big Brother) in thisDNA binding affinity appears significantly larger in the
EMSA experiments compared with that obtained by the organism [39].
As shown by the various crystal structures [28–30], theSPR data as a result of protein instability and precipita-
tion during incubation with DNA [29, 31]. The DNA bind- L11-II conformation and the associated long hydrogen
bond zipper are further stabilized by CBF via directing affinity of the RD (Asp66Ala)/CBF heterodimer, on
the basis of the SPR data, is similar to that for the wt interaction with Thr149 (10), as well as by supporting
L1 and L10 loops through a hydrogen-bonded networkcomplex [29]. Hence, it is likely that the constructive
effect of this modification on the interaction between involving Asn69 (L1), Thr154 (L10), and Gln158 (11),
illustrated in Figure 5B. Only in the presence of CBF isthe two proteins makes up for its destabilizing effect on
the DNA-compatible conformation of L11. The effect of Asn69 of L11 properly aligned to form optimally oriented
hydrogen bonds with the backbone of L4 as well as withThr161 substitution in RD was studied for Thr161Arg
mutant, showing a drastic reduction in heterodimeriza- Gln158 at the end of L10, which, in turn, interacts with
Thr154 of the same loop. Another support of the flexibletion with essentially no influence on DNA binding [31].
This finding is again in accord with the current model L4 loop is provided by Gln127 forming three hydrogen
bonds with the L4 backbone, again, only in the presenceas follows: the bulky Arginine residue could form a salt
bridge with Asp66 to buttress the L11-II conformation of CBF (Figure 5B). The critical roles of Thr154 and
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Figure 4. Comparison between the Free and
the Complexed RD and DNA Molecules
The free RD and its DNA target (magenta)
superimposed on the corresponding mole-
cules of the RD/CBF/DNA complex (cyan
and blue).
Gln158 have been demonstrated by the corresponding L9 loop is properly aligned to interact with the DNA
target. The L9 loop, in turn, supports the other structuraldisease-associated mutations [36, 37]. The multifunc-
tional interloop hydrogen bonds formed by Asn69 and motifs that interact with DNA (shown in Figure 3A),
thereby contributing to the stability of the entire protein-Gln127 underscore their role in supporting the top four
loops of RD. DNA interface. The RD amino acids involved in the
CBF-mediated support of the triple loop configurationThe other major support to the triple loop configura-
tion in the DNA binding mode is through direct hydrogen described above are conserved among the mammalian
RD proteins, and the critical roles of several of them inbonds between CBF and the L5 loop involving Tyr113
and Ser114 (indicated in Figure 2A). The stabilizing inter- heterodimerization and DNA binding have been demon-
strated by mutational studies [29–31]. However, RD pro-actions within each of the L5 and L9 loops are similar
between the free and the bound molecules (Figure 5A). teins of other species, such as the Drosophila Runt and
Lozenge and the C. elegans Run, show nonhomologousHowever, the interaction between the two loops is en-
hanced in the RD/DNA/CBF complex as a result of the substitutions in the above amino acids and in neigh-
boring residues (see above). It is therefore likely that insupporting contacts of CBF with L5. The additional
stabilizing interactions observed in the ternary complex certain species, the DNA compatible conformation of
the triple loop (L11-L9-L5) is already predominant in theinclude salt bridges formed by Lys144 with Asp110 and
Glu111 as well as hydrogen bonds involving the amino free state of the RD protein, and, hence, a CBF-like
partner protein is either not required for augmentinggroups of Asn109 and Asn112. These interactions are
not observed in either the free RD or the RD/DNA com- DNA binding or its role extends beyond this function. The
structural and functional effects of amino acid changesplex, except for those of Asn109 in the free RD molecule
(shown in Figure 5A) because the two loops in these shown by the various RD proteins are presently studied
in our laboratory.structures are further apart compared with those of the
ternary complex. The deleterious effects of Asn109 mu-
tations on heterodimerization and DNA binding point to The Structural Role of Disease-Related Protein-
DNA Interactionsthe central role of this amino acid in reinforcing the two
loops [29, 31, 34]. Mutations in the Runt domain that interfere with protein-
DNA interactions (Arg80, Lys83, Arg135, Arg139,To summarize, the direct contacts of CBF with L1,
10, L10, 11, and L11 on one side of the L11-L9-L5 Arg142, Asp171, Arg174, and Arg177) were found in
acute myelogenous leukemia (AML), familial platelet dis-triple loop and with L5 on the other side ensure that the
Figure 3. Conformational Changes in the Runt Domain upon Binding to DNA and to CBF
(A) A view of the RD regions that interact with DNA. Superimposed are the corresponding structures of the free RD (magenta) and the RD/
DNA complex (green). The amino acids that interact with the DNA are shown as transparent. The amino acids that stabilize this surface by
intramolecular hydrogen bonds and van der Waals interactions are shown as solid. Attractive electrostatic interactions are shown as dotted
lines.
(B) A comparison between the two conformations of the L11 loop (L11-I and L11-II) and the associated orientations of the L9 loops in the
free RD (magenta) and the DNA-bound RD (green). Side chains are transparent. Hydrogen bonds are shown as dotted lines.
(C) A view showing the interactions of RD with CBF that stabilize the L11-II conformation. The hydrogen-bonded triad T161-D66-H163 of
RD (cyan) is supported through hydrogen bonds and hydrophobic interactions with CBF (blue). The same region of RD from the RD/DNA
complex (green) is also shown, for comparison.
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Table 1. Sequence Comparison of L11 Amino Acids in RD Proteinsa
Protein Species ID 161 66 163
RUNX1 Homo sapiens (human) Q01196 Thr Asp His
RUNX2 Homo sapiens (human) Q13950 Thr Asp His
RUNX3 Homo sapiens (human) Q13761 Thr Asp His
Runx2 Mus musculus (mouse) Q08775 Thr Asp His
Xaml Xenopus laevis (African frog) O73725 Thr Asp His
Runx1 Brachydanio rerio (zebrafish) Q9DGB8 Thr Asp Gln
SpRunt Strongylocentrotus purpuratus (purple sea urchin) Q26628 Thr Glu Asn
Runt Drosophila virilis (fruit fly) Q24709 Ser Gly Ser
Lozenge Drosophila melanogaster (fruit fly) Q24183 Thr Ser Ala
Run Caenorhabditis elegans (nematode) O01834 Thr Ser Lys
a Amino acid sequence accession numbers are for the SWISS-PROT and DDBJ/EMBL/GenBank databases. Numbering of amino acids (161,
66, and 163) corresponds to the human RUNX1 (AML1) [1].
order (FPD), cleidocranial dysplasia (CCD), and myelo- one at a time by alanine residues, resulted in drastic
reduction of the DNA binding affinity [29, 30]. Such inter-dysplastic syndrome (MDS) [34, 36, 37, 40–44]. Modified
RD molecules, where these amino acids were replaced ference is caused not only by the loss of hydrogen bond-
Figure 5. Stabilizing Interactions between Adjacent Loops in the Free and Complexed RD Structures
(A) L5-L9 interactions in the free RD molecule (magenta) and in the RD/CBF/DNA complex (cyan).
(B) Comparison of the top loops (L1, L4, L7, and L10) in the free and complexed RD structures. ID and color codes are as in Figure 1C. Amino
acid side chains that are involved in intra- and interloop interactions are shown. For clarity, only interloop hydrogen bonds are shown (dotted
lines). Atoms that interact with CBF in the RD/CBF/DNA complex (cyan) are shown as large spheres.
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Figure 6. Superposition of the Three DNA
Binding Sites, Ten Base Pairs
The free DNA (magenta), the DNA bound to
RD (green; ID code 1HJC), and the DNA
bound to RD/CBF (cyan; ID code 1H9D). The
view is along the dyad axis through the
center.
ing interactions, but also, perhaps to a greater extent, by The Structure of the Free DNA Binding Site
Is Compatible with the Protein-Bound Formimpairment of the spatial arrangement of the structural
The RD binding site is a 7-mer DNA duplex of the con-elements that constitute the protein-DNA surface. In
sensus sequence PyGPyGGTPy and its complementaryparticular, Arg174 anchored at the DNA major groove
strand. The sequence used here for the free DNA crystalplays a key role in buttressing the L12 loop, as well
structure is TGCGGTC incorporated in a dodecamer,as the sequence-specific interactions of Asp171 and
AGCTGCGGTCAT (underlined). The crystal structureArg177 at both sides. Destabilization of L12 as a result
represents a new packing arrangement of DNA dodeca-of mutations in Arg174 would propagate through the
mers, where the molecules are “loosely” packed (volumeother constituents of the protein-DNA interface (shown
per base pair is 1618 A˚3; see Experimental Procedures).in Figure 3A), leading to dysfunction. The crucial role of
Interduplex contacts in the crystal are end to end base-Arg174 is underscored by the prevalence of mutated
stacking and backbone/major-groove interactions simi-proteins (Arg174Gln and Arg174Trp) in several of the
lar to those observed in previously reported DNA regula-above-mentioned diseases [36, 37, 41, 43]. Also,
tory elements [45–47]. It is therefore likely that the crystalArg174Ala mutation was shown to totally abolish DNA
structure of the free RD binding site closely representsbinding activity, whereas the activity of Asp171Ala and
its conformation in solution.Arg177Ala mutants could be partially rescued by an
The binding site used for the crystal structure of the
excess of CBF [29]. Similarly, the considerable reduc-
RD/DNA complex was TGTGGTT embedded in a 16-
tion in binding affinity shown by mutations such as mer [29], and that for the RD/DNA/CBF complex was
Arg142Cys [37] or Arg142Ala [29, 30] cannot be attrib- TGCGGTT within a decamer [30]. The two duplexes su-
uted solely to the loss of protein-DNA minor-groove perimposed on the free DNA helix (central ten base pairs)
interactions, but rather to the loss of support provided are shown in Figure 6. The conformations of the protein-
by hooking the L9 loop onto the DNA in a position that bound DNA helices are highly similar. The conserved
reinforces the other structural elements that contribute seven-base pair region of the free helix is similar to
to DNA binding (Figure 3A). Disease-related mutations each of the complexed helices, whereas relatively large
in amino acids that form nonspecific contacts with the changes are shown by the regions outside the consen-
DNA backbone, Arg135Gly [43], Arg139Gln [37, 41], and sus one, probably because of end effects and alterations
Arg139Gly [42], should also be attributed to the loss of in the base sequences. The RMS deviations between
interactions that support protein loops (L3 by Arg135 the free seven-base pair target and each of the bound
and L9 by Arg139) at the protein-DNA interface (Figures DNA sequences (with all common atoms) is 1.2 A˚, com-
pared with 0.6 A˚ between the two bound DNA targets.3A and 4).
Table 2. Average DNA Parametersa
Groove Width (A˚) Groove Depth (A˚)
Helix
DNA Sequence Inclination () Roll () Twist () Rise (A˚) Slide (A˚) Dx (A˚) Major Minor Major Minor
AGCTGCGGTCATb 5.2 4.3 34.3 3.2 0.1 0.2 11.8 6.7 9.3 7.7
-CTCTGTGGTTGC-c 6.4 4.1 33.2 3.3 0.2 1.3 12.3 7.5 10.7 7.2
GTTGCGGTTGd 6.4 4.0 33.0 3.3 0.1 0.9 12.6 7.4 10.4 7.5
B-DNAe 2.9 1.5 36.0 3.4 0.5 0.6 11.4 5.9 8.4 8.5
a All parameters were calculated with FREEHELIX [60] as described by [46].
b Present study.
c The central 12-base pair fragment of the 16-mer used in the crystal structure of the RD/DNA complex [29].
d The DNA decamer used for the crystal structure of the RD/CBF/DNA complex [30].
e Fiber-derived B-DNA [57].
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All DNA helices display a significant bend into the Although the first and third base pairs of the DNA
major groove localized at the central consensus se- target are not involved in direct interactions with the
quence. The overall bending of the seven-base pair rec- protein [29, 30], their high conservation as pyrimidine-
ognition site (based on the relative orientation of the purine steps of the type T-G/C-A or C-G points to their
end base pairs) is 16 in the free DNA and 23 and 22 structural role in the recognition process. Pyrimidine-
in the binary and ternary complexes (Protein Data Bank purine sites were shown to stand out as the most vari-
codes 1HJC and 1H9D, respectively). A meaningful com- able steps in DNA helices and in DNA-protein com-
parative analysis of DNA curvature and other helical plexes, thereby providing flexibility or deformability to
parameters as a function of the base sequence should the double helix that facilitates the formation of the pro-
await higher-resolution analyses of the crystal struc- tein-DNA interface [46, 52]. Hence, the presence of such
tures. However, the average conformational parameters flexible hinges, combined with the notable similarity be-
of the DNA helices based on the current crystal struc- tween the free and the complexed duplexes, indicates
tures, analyzed at a resolution range of 2.6–2.8 A˚, can that the transition from the free to the bound DNA confor-
be reliably compared with each other, as shown for other mation is accomplished at minimal, or no, energy cost.
DNA binding sites [46]. The structural role of the DNA binding site in providing
The mean helical parameters of the three structures specificity to protein-DNA interactions has been already
are given in Table 2. These values demonstrate that all demonstrated in several systems where data were avail-
duplexes display a B-DNA conformational variant ob- able on both the free and the protein-bound DNA confor-
served previously for the DNA binding sites of the E2 mations [45–47]. The present findings on the Runt do-
transcription regulator of bovine papillomavirus [46]. main binding sites further corroborate the concept of
This form, referred to as WB-DNA (for writhed B-DNA), the “structural code for DNA recognition.”
is characterized by a gentle roll-induced writhe, so that
the base pairs are positively inclined to the helix axis
by 4–7 and the mean local roll angle is in the range Biological Implications
from 3 to 5, a helical repeat that is significantly greater
than 10 bp/turn, similar to the value derived for DNA in Transcriptional regulation depends on sequence-spe-
solution, a deep major groove, and a wide minor groove cific binding of transcription factors to their DNA binding
in comparison with regular B-DNA [46]. The average sites as well as their interaction with partner proteins.
helical parameters of the three DNA helices (Table 2) Understanding the mechanisms of DNA recognition in
are in accordance with those expected for WB-DNA and such systems is a challenging task, since subtle confor-
are similar to each other. The major groove of each of the mational changes in the protein and in the DNA target
complexed DNA molecules is deeper, by approximately can significantly affect the stability of the protein/DNA
1 A˚, relative to that of the free target. The major-groove assembly. This is also the case of DNA recognition by
deepening associated with enhanced bending and mi- the mammalian RUNX proteins that are key regulators of
nor-groove widening relative to the free DNA target ap- major developmental pathways, such as hematopoietic,
pear to optimize the interactions between critical amino osteogenic, and neurogenic lineage-specific gene ex-
acids of the Runt domain and the specific base pairs at
pression, and, when mutated, they are associated with
the major and minor grooves, as illustrated in Figure 4.
acute leukaemia and bone disorder [20–22]. The RUNX
The crystal structures of the RD/DNA and RD/DNA/
proteins recognize a consensus DNA sequence throughCBF complexes show that the DNA binding site ex-
their highly conserved DNA binding domain, known astends beyond the consensus heptamer PyGPyGGTPy,
the Runt domain (RD). The Runt domain also mediatesas Arg142 forms hydrogen bonds with two consecutive
binding to CBF, an unrelated partner protein, whichbases (positions 7 and 8) at the DNA minor groove [29,
does not interact directly with DNA but enhances the30]. The bidentate interaction of Arg142 with the two
DNA binding affinity of the RUNX protein. In order tobases at the minor groove (A and C of the complemen-
reveal the mechanism of DNA recognition in this system,tary strand) is less specific than the interactions formed
we require a knowledge of the structures of all compo-by the other basic or acidic amino acids with bases at
nents in their free and complexed forms.the major groove. This is because the N3 atom of a
We determined the crystal structures of the RUNX1purine base and the O2 atom of a pyrimidine base that
RD and its DNA binding site in their free states andact as hydrogen-bond acceptors are exchangeable, as
compared them with the reported structures of RDdemonstrated previously by interduplex DNA interac-
bound to DNA and to CBF. The comparative analysistions and minor-groove binding proteins [48]. However,
of the various structures in relation to the available bio-the positioning of such minor-groove atoms can be
chemical and genetic studies provides new insights intofinely tuned by sequence-dependent base-stacking in-
the mechanism of protein-DNA recognition in this sys-teractions and thus affect the recognition specificity.
tem. We show that the structural elements that compriseThe identity of sequences flanking the recognition site
the DNA contact surface, with the exception of one loopare also likely to influence the DNA binding and bending
(L9) and the extreme C terminus, are properly structuredcharacteristics. Such effects may explain significant dif-
and oriented in the free Runt domain, as required toferences in the DNA binding affinity of the same RD
form direct and water-mediated protein-DNA interac-construct by using DNA targets with T-T or T-A base
tions with the bases at the DNA major groove and withpair doublets at the 3-end or with different flanking
the DNA backbone. A major realignment of the L9 loopsequences [33, 49, 50] as well as enhanced DNA bending
occurs upon DNA binding, allowing the formation ofby the heterodimeric protein in comparison with the RD
protein [51]. hydrogen bonds between the protein and the bases
DNA Recognition by the RUNX1 Transcription Factor
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Table 3. X-Ray Data and Refinement Statisticsa
Runt Domain DNA Binding Site
Resolution limits (A˚) 43.0–2.5 25.0–2.8
Measured reflections/I  0 243,124 6,369
Unique reflections/F  2(F) 17,379/15,686 1,846/1,719
Upper resolution shell (A˚) 2.54–2.50 2.9–2.8
Completeness of data (%) 99.3 (99.8) 98.4 (93.3)
Rsym(I ) (%) 7.1 (29.5) 6.8 (32.8)
R factor/Rfree (%)b 19.3/24.9 23.3
Number of atoms/water molecules/chloride ions 1759/203/5 486
Rms deviations
Bond length (A˚) 0.007 0.02
Bond angle () 1.2 2.5
Bonded B factor (A˚2) 3.8 4.6
1 The values in parentheses refer to the upper resolution shell.
2R factor  	|Fo  |Fc||/	Fo, including all data with Fo  0. Rfree was calculated with 5% of the data excluded from the refinement. Rfree was
not monitored in the refinement of the DNA structure because of the limited data.
were performed at 4C. Gel filtration chromatography showed oneexposed at the minor groove as well as with the DNA
main peak corresponding to the monomer, with a final yield of 40backbone. This change is achieved by an allosteric tran-
mg per liter of culture. The DNA binding activity of the refoldedsition in RD accommodated by cooperative changes in
protein was confirmed by electrophoretic mobility gel shift assay
three loops: L11, L9, and L5. The DNA-induced con- with a DNA decamer, GCTGCGGTCA, incorporating the heptameric
formational transition in the Runt domain is further consensus site (underlined). The protein was mixed with this DNA
target (at a molar ratio) and concentrated to 8–12 mg/ml.supported by CBF through hydrogen bonding and hy-
drophobic interactions, thus explaining the enhance-
ment in DNA binding affinity of the RD/CBF hetero- Crystallization, Data Collection, and Structure Solution
of the Runt Domaindimer relative to RD. The DNA binding site of the Runt
Initial crystallization trials of the protein/DNA complex were done bydomain in its free form is predisposed to adopt a unique
the hanging drop method with commercial crystal screens (Hamptonbent conformation similar to that observed in the com-
Research). Only one condition (screen II #8) yielded diffraction qual-
plex with the protein. Hence, the conformational fea- ity crystals of rhombohedral morphology. The final conditions used
tures of the DNA target are intrinsic to the specific base were 6% ethanol, 1.4–1.5 M NaCl, 100 mM Tris buffer (pH 7.5), and
20 mM DTT. Crystals grew within 3–4 days and continued to growsequence and contribute to its recognition by the RD
for 5–7 days to a maximum size of 0.08 mm at the longest side ofprotein. To conclude, the specificity of protein-DNA in-
the crystals.teraction in the RUNX1 system is conferred by the spe-
Before data collection the crystals were soaked in a cryoprotec-cific interactions formed by the critical amino acids with
tant solution containing 20% glycerol and the crystallization buffer
the DNA bases and the backbone as well as by the and flash-cooled to 100 K. Diffraction data to 2.5 A˚ resolution were
intrinsic DNA conformation encoded by the particular collected on an R axis IV detector mounted on a Rigaku ultraX
18 rotating anode source with CuK radiation focused by Osmicbase sequence.
confocal mirrors. Intensity data were processed by DENZO andTo date, less than a handful of gene-regulatory sys-
SCALEPACK [53]. The space group is R32, with unit cell dimensionstems are known where detailed structural information
of a  b  121.23 A˚ and c  186.33 A˚. The lack of a typical strongis available on the interacting components in both their
3.3–3.4 A˚ DNA transform in the diffraction data indicated that no
free and bound forms. The present study demonstrates DNA is present in the crystal, as was later confirmed by the structure
that such comprehensive knowledge provides a better solution.
The crystal structure was solved by the molecular replacementstarting point for understanding the intricate mechanism
method MFT/ULTIMA [54], with the Runt domain from the crystalby which transcription regulators recognize their DNA
structure of the RD/CBF complex [28] as a search model (Proteintargets.
Data Bank code 1E50). The crystal structure contains two RD mole-
cules in the asymmetric unit, indicating a high solvent content (moreExperimental Procedures
than 70%). The structure was refined with CNS [55]. Nine residues
at the N terminus (51–59) and seven residues at the C terminusProtein Production and Purification
(175–181) were highly disordered and, therefore, not included in theThe Runt domain of the human RUNX1 protein (residues 51–181)
final model. Data and refinement statistics are in Table 3.was overexpressed in E. coli (with heat shock promoter, 
pL) and
extracted from the inclusion bodies with 20 mM HCl (pH 2–3). The
protein was then purified by HPLC reversed phase chromatography, DNA Purification, Crystallization, Data Collection,
and Structure Determinationwith 0.1% TFA as buffer A and acetonirile as buffer B, and lyophi-
lized. N-terminal analysis and electron spray mass spectrometry Two DNA oligomers, GCTGCGGTCA and AGCTGCGGTCAT, and the
corresponding complementary strands incorporating the consensusconfirmed the identity of the protein. The protein was then dissolved
in water and 20 mM DTT and dialyzed against 200 mM sodium sequence (underlined) were synthesized on a commercial synthe-
sizer (Applied Biosystems). The DNA fragments were purified byacetate buffer (pH 5.2) and 20 mM DTT. Gel filtration chromatogra-
phy showed that most of the protein (85%) was in aggregated form HPLC reversed phase chromatography and then dialyzed against
double-distilled water and lyophilized. The two complementaryand required refolding. The aggregated protein was dialyzed against
7 M urea, and then the dialysis buffer was changed gradually by strands of each sequence were mixed at molar ratio and annealed
in 10 mM MgCl2 and 20 mM NaCl. Crystallization experiments ofdecreasing the concentration of urea in the presence of 40 mM
-mercaptoethanol. The final dialysis was done against 50 mM the duplex AGCTGCGGTCAT/ATGACCGCAGCT were performed ei-
ther at 19C or at 4C. The best crystals were grown at 19C fromHEPES buffer (pH 7.5), 150 mM NaCl, and 20 mM DTT. All steps
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5 l hanging drops containing 2 mg/ml DNA, 20 mM MgCl2, 2 mM TLE/Groucho corepressors. Proc. Natl. Acad. Sci. USA 95,
11590–11595.ZnCl2, 5 mM spermine.4HCl, 20 mM Na cacodylate buffer (pH 7.0),
and 10% (w/v) MPD equilibrated against a reservoir of 27.5% (w/v) 11. Simeone, A., Daga, A., and Calabi, F. (1995). Expression of runt
in the mouse embryo. Dev. Dyn. 203, 61–70.MPD. Very thin crystals appeared within 4–6 weeks and grew to a
maximum size of 0.1  0.1  0.008 mm3. 12. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K.,
Deguchi, K., Shimizu, Y., Bronson, R.T., Gao, Y.H., Inada, M.,Crystals were covered with Exon paraton oil as a cryoprotectant
and flash-cooled at 100 K. Diffraction data to 2.8 A˚ resolution were et al. (1997). Targeted disruption of Cbfa1 results in a complete
lack of bone formation owing to maturational arrest of osteo-collected on an R axis IV detector mounted on a Rigaku RU-
H3R rotating anode source with CuK radiation focused by Osmic blasts. Cell 89, 755–764.
13. Otto, F., Thornell, A.P., Crompton, T., Denzel, A., Gilmour, K.C.,confocal mirrors and processed as described for the Runt protein.
The space group is C2, with a  75.1, b  27.2, c  40.5 A˚, and Rosewell, I.R., Stamp, G.W., Beddington, R.S., Mundlos, S.,
Olsen, B.R., et al. (1997). Cbfa1, a candidate gene for cleidocra-  110.7 and with one duplex DNA in the asymmetric unit, corre-
sponding to a volume per base pair of 1618 A˚3. The structure was nial dysplasia syndrome, is essential for osteoblast differentia-
tion and bone development. Cell 89, 765–771.solved by ULTIMA [56], with a fiber-derived B-DNA model [57], and
14. North, T., Gu, T.L., Stacy, T., Wang, Q., Howard, L., Binder, M.,refined with CNS [55]. X-ray data and refinement statistics are given
Marin-Padilla, M., and Speck, N.A. (1999). Cbfa2 is required forin Table 3.
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